GSK
790 hedge funds and large institutions have $12.4B invested in GSK in 2021 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 296 increasing their positions, 231 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
790
Holders Change
-7
Holders Change %
-0.88%
% of All Funds
13.87%
Holding in Top 10
13
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.14%
% of All Funds
0.23%
New
74
Increased
296
Reduced
231
Closed
68
Calls
$327M
Puts
$163M
Net Calls
+$164M
Net Calls Change
+$97M
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$129M |
| 2 |
Two Sigma Advisers
New York
|
+$125M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$73.7M |
| 4 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
+$47.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$19.5M |
Top Sellers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$147M |
| 2 |
CA
Capitolis Advisors
New York
|
-$60.7M |
| 3 |
Barclays
London,
United Kingdom
|
-$43.1M |
| 4 |
JEST
JTC Employer Solutions Trustee
St Helier,
Jersey
|
-$41.7M |
| 5 |
BCAM
Boston Common Asset Management
Boston,
Massachusetts
|
-$28.4M |
